Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

B. Strober, M. Buonanno, J. D. Clark, T. Kawabata, H. Tan, R. Wolk, H. Valdez, R. G. Langley, J. Harness, A. Menter, K. Papp

Research output: Contribution to journalArticlepeer-review

85 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology